Introduction: Targeting Different Pathways to Prevent Tumor Cell DevelopmentKANTARJIAN, Hagop M.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S1-S5, SUP1Article

Purine nucleoside phosphorylase (PNP): a novel target in leukemias and lymphomasKANTARJIAN, Hagop M.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, 41 p., SUP5Serial Issue

Targeting Different Pathways to Prevent Tumor Cell DevelopmentKANTARJIAN, Hagop M.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, 59 p., SUP1Serial Issue

Novel therapies for myelodysplastic syndromesFADERL, Stefan; KANTARJIAN, Hagop M.Cancer. 2004, Vol 101, Num 2, pp 226-241, issn 0008-543X, 16 p.Article

Cell Culture Modeling of Genotype-Directed Sensitivity to Selective Kinase Inhibitors: Targeting the Anaplastic Lymphoma Kinase (ALK)SETTLEMAN, Jeff.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S36-S41, SUP1Article

Role of c-Met in Cancer: Emphasis on Lung CancerSALGIA, Ravi.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S52-S58, SUP1Article

New strategies in chronic myeloid leukemia : PIH: New era of leukemia therapyKANTARJIAN, Hagop M; CORTES, Jorge.International journal of hematology. 2006, Vol 83, Num 4, pp 289-293, issn 0925-5710, 5 p.Article

Chronic Myelogenous LeukemiaKANTARJIAN, Hagop M; TALPAZ, Moshe.Hematology/oncology clinics of North America. 2004, Vol 18, Num 3, issn 0889-8588, 274 p.Serial Issue

Adult acute lymphocytic leukemia : Future research directionsKANTARJIAN, Hagop M.Hematology/oncology clinics of North America. 2001, Vol 15, Num 1, issn 0889-8588, viii,207-211 [6 p.]Article

Decitabine dosing schedulesKANTARJIAN, Hagop M; ISSA, Jean-Pierre J.Seminars in hematology. 2005, Vol 42, Num 3, pp S17-S22, issn 0037-1963, SUP2Article

Lymphoblastic lymphomaTHOMAS, Deborah A; KANTARJIAN, Hagop M.Hematology/oncology clinics of North America. 2001, Vol 15, Num 1, issn 0889-8588, vi,51-95 [46 p.]Article

Adult acute lymphocytic leukemia : Introduction and questions related to current programsKANTARJIAN, Hagop M.Hematology/oncology clinics of North America. 2000, Vol 14, Num 6, issn 0889-8588, vii,1205-1208 [5 p.]Article

The hyper-CVAD regimen in adult acute lymphocytic leukemiaGARCIA-MANERO, Guillermo; KANTARJIAN, Hagop M.Hematology/oncology clinics of North America. 2000, Vol 14, Num 6, pp x-xi, issn 0889-8588, 18 p.Article

Three New Drugs for Acute Lymphoblastic Leukemia : Nelarabine, Clofarabine, and ForodesineLARSON, Richard A.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, S13-S20, SUP5Article

Adult acute myeloid leukemiaJABBOUR, Elias J; ESTEY, Elihu; KANTARJIAN, Hagop M et al.Mayo Clinic proceedings. 2006, Vol 81, Num 2, pp 247-260, issn 0025-6196, 14 p.Article

Current therapy of chronic myelogenous leukemiaGARCIA-MANERO, Guillermo; TALPAZ, Moshe; KANTARJIAN, Hagop M et al.Internal medicine (Tokyo. 1992). 2002, Vol 41, Num 4, pp 254-264, issn 0918-2918Article

Adult acute lymphoblastic leukemiaJABBOUR, Elias J; FADERL, Stefan; KANTARJIAN, Hagop M et al.Mayo Clinic proceedings. 2005, Vol 80, Num 11, pp 1517-1527, issn 0025-6196, 11 p.Article

Animal models of chronic myelogenous leukemiaILARIA, Robert L.Hematology/oncology clinics of North America. 2004, Vol 18, Num 3, issn 0889-8588, vii, 525-543 [20 p.]Article

Advances in the treatment of adult acute lymphocytic leukemia, part IIKANTARJIAN, Hagop M; HOELZER, Dieter; LARSON, Richard A et al.Hematology/oncology clinics of North America. 2001, Vol 15, Num 1, issn 0889-8588, 225 p.Serial Issue

Advanced in the Treatment of Adult Acute Lymphocytic Leukemia, Part IKANTARJIAN, Hagop M; HOELZER, Dieter; LARSON, Richard A et al.Hematology/oncology clinics of North America. 2000, Vol 14, Num 6, issn 0889-8588, 204 p.Serial Issue

Proteasome Inhibitors in Multiple MyelomaANDERSON, Kenneth C.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S20-S26, SUP1Article

Understanding DNA Damage Response and DNA Repair Pathways: Applications to More Targeted Cancer TherapeuticsKINSELLA, Timothy J.Seminars in oncology. 2009, Vol 36, Num 2, issn 0093-7754, S42-S51, SUP1Article

Molecular Monitoring in Chronic Myeloid Leukemia : Response to Tyrosine Kinase Inhibitors and Prognostic ImplicationsJABBOUR, Elias; CORTES, Jorge E; KANTARJIAN, Hagop M et al.Cancer. 2008, Vol 112, Num 10, pp 2112-2118, issn 0008-543X, 7 p.Article

Emerging role of epigenetic therapy: focus on decitabineISSA, Jean-Pierre J; KANTARJIAN, Hagop M.Seminars in hematology. 2005, Vol 42, Num 3, issn 0037-1963, 61 p., SUP2Serial Issue

Changes in DNA methylation in neoplasia : Pathophysiology and therapeutic implicationsSANTINI, Valeria; KANTARJIAN, Hagop M; ISSA, Jean-Pierre et al.Annals of internal medicine. 2001, Vol 134, Num 7, pp 573-586, issn 0003-4819Article